An underground market for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.
Investigational Drug Acquiring Popularity Via Social Media
The experimental drug, which is still in research studies, is being promoted by online personalities for its alleged fat-burning properties. Viewers are urged to message these profiles privately for supplier links, while also receiving discount codes.
Active Commerce on Social Networks
Separately, a flourishing trade exists on messaging services, where communities with numerous of members share comparison photos, injection guides and assertions of next-day British shipping. Vendors promote the substance there before redirecting customers to WhatsApp for purchases.
Understanding The Experimental Drug
Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.
Healthcare Professionals Voice Concerns
Nevertheless, doctors and pharmacists have cautions that the sale of what remains an unapproved drug in the UK is worrisome and could lead to individuals injecting products of unknown origin.
Some experts said the popularity for retatrutide could be connected to the increasing price of approved weight loss products such as Mounjaro.
Legal Status and Enforcement
Selling retatrutide on TikTok or Telegram is illegal in the UK, as it is an unapproved drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Some content creators attempt to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still violate medicines, marketing, and consumer laws, potentially leading to fines, prosecution or imprisonment.
Service Reaction and Content Removal
According to TikTok, the platform has taken down problematic material and prohibited associated hashtags and query recommendations. The organization said it was committed to maintaining the platform secure and allocating resources in strengthening enforcement strategies.
Online Marketplace Operations
Investigations also found communities with up to 9,000 members marketing retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays groups with thousands of users, populated with images of slimming results, glowing testimonials and step-by-step instructions for preparing or injecting at home.
Within moments of entering one group, a vendor posted WhatsApp details, where the majority of purchases occur. The vendor provided an instruction manual and promised shipping within two days. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about weight, health issues or past usage.
Item Details and Pricing
Inside these communities, messages show dark colored parcels with Royal Mail stickers, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20 milligrams. When questioned how long a injector should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.
Platform Moderation and Security Actions
A spokesperson for Telegram stated it regularly monitored harmful material on its platform including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are administering materials they can’t verify. Although the science behind this drug is sound, these digital versions may not include what they advertise,” stated Jason Murphy, the head of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the increase in demand to recent price rises for authorized slimming medications such as Mounjaro. “With prices increasing, patients are turning to online platforms. But fake treatments are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she said.
Her team has previously seen individuals harmed by personal administration from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or communication platforms is gambling with your health,” stated the doctor. “These substances could be impure or incorrectly dosed.”
Manufacturer Statement
A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly experimental substance not yet approved … may expose patients to possibly serious health risks”.
